DisclaimerDisclaimer

The following information is provided by Excelsior Med ical Co., Ltd. and may contain forward-looking statements based on current situation. Excelsior makes no guarantee or warranties as for the accuracy or correctness of such statements. Actual re sults may differ materially from those expressed or implied b y such statements due to known and unknown risks and uncerta inties. Except as required by law, we are not responsible to update or revise those forward-looking statements to reflect subsequentcircumstances.

Financial information in this presentation is reviewed by CPA.

2

The Most professional total healthcare solution pro vider amongThe Most professional total healthcare solution pro vider amongAsia with exceptional investing and operating teamAsia with exceptional investing and operating team

Excelsior Healthcare GroupExcelsior Healthcare Group , founded in 1980, beginning with the sales of , founded in 1980, beginning with the sales of hemodialysis equipment and channel operation, the c ompany expandhemodialysis equipment and channel operation, the c ompany expand ed its ed its horizon into diversified medical services incorpora ting longhorizon into diversified medical services incorpora ting long --term medical term medical care, logistics, information technology, consumer a ppliance and care, logistics, information technology, consumer a ppliance and medical medical aesthetic. With its success in integration and div ersification,aesthetic. With its success in integration and div ersification, EHG reached EHG reached the milestone of being the public listed company on the TSE markthe milestone of being the public listed company on the TSE mark et in 2007.et in 2007.

In light of the magnetic effect of China and global trend, combiIn light of the magnetic effect of China and global trend, combi ning the ning the corporate strength, EHG move full stream ahead in e xploring the corporate strength, EHG move full stream ahead in e xploring the Chinese Chinese market and the possibility of future biotech. Toge ther with itsmarket and the possibility of future biotech. Toge ther with its strategic strategic alliance partners, EHG expect to construct an excep tional investalliance partners, EHG expect to construct an excep tional invest ing anding andoperating team in the Asian healthcare industry.operating team in the Asian healthcare industry.

3

Vision & Values

Dedication 、、、、Discipline 、、、、Innovation 、、、、Proactive“Dedication, Discipline, Innovation, Proactive” are the core values of Excelsior Group.

“Human Care” is the basis of medical service.

Therefore, “Dedication” to our service target is what matters the most.

We focus on public healthcare, using innovative management model,

providing the most suitable product and service to the market.

And achieve our vision of becoming

the most professional total healthcare solution provider among Asia.

4

Our Core CompetencyOur Core Competency -- PartnershipPartnership

PRODUCT COMMITMENTPRODUCT COMMITMENT

MINORITY INTERESTMINORITY INTEREST

ALLIANCEALLIANCE

JOINT VENTUREJOINT VENTURE

PARTNERSHIPPARTNERSHIP

5

Channel

ProductTrading/Services

Provider/Partner

Consumer

Value Chain IntegrationValue Chain Integration

6

(2) Integrated Service Provider• Economic Scale• Customer loyalty

(1) Products & Services Innovation• Reduce procurement cost• Reaction of market needs

(3) Strategy & Execution• Organization innovation• Business model• Information system solution

• Shorter lifecycle• High brand value• Relative lower entry barrier

• Higher profit margin • Lower patient volume• High revenue growth• High Loyalty to

Practitioner and Institute

Characteristics of Elective DiseaseCharacteristics of Elective Disease• Relative lower profit

margin • Vast patient volume• Stable patient source

• Repeat use• High loyalty to

Institute• High brand value

Characteristics of Selected Chronic DiseaseCharacteristics of Selected Chronic Disease

Smiling CurveSmiling CurveSelected Competitive Sectors of Excelsior Selected Competitive Sectors of Excelsior

AdAd--hochocRepetitiveRepetitive Patronization PatternPatronization Pattern

Rel

ativ

e P

rofit

abili

tyR

elat

ive

Pro

fitab

ility

Hig

hH

igh

Med

ium

Med

ium

Low

Low“Volume Business”- Chronic Disease -

“Value Business” -Elective Surgery -

• Ophthalmology

• Medical Skincare

• Dialysis

• RT

• Long Term Care

• Logistics

• Preventive Medicine

• Medical Equipment Trading & Maintenance• Rehabilitation

• Pediatrics

• Obstetrics and Gynecology• ENT

• Hair Transplant• Anti-aging

• Shorter lifecycle• High brand value• Relative lower entry barrier

• Higher profit margin • Lower patient volume• High revenue growth• High Loyalty to

Practitioner and Institute

Characteristics of Elective DiseaseCharacteristics of Elective Disease• Shorter lifecycle• High brand value• Relative lower entry barrier

• Higher profit margin • Lower patient volume• High revenue growth• High Loyalty to

Practitioner and Institute

Characteristics of Elective DiseaseCharacteristics of Elective Disease• Relative lower profit

margin • Vast patient volume• Stable patient source

• Repeat use• High loyalty to

Institute• High brand value

Characteristics of Selected Chronic DiseaseCharacteristics of Selected Chronic Disease• Relative lower profit

margin • Vast patient volume• Stable patient source

• Repeat use• High loyalty to

Institute• High brand value

Characteristics of Selected Chronic DiseaseCharacteristics of Selected Chronic Disease

Smiling CurveSmiling CurveSelected Competitive Sectors of Excelsior Selected Competitive Sectors of Excelsior

AdAd--hochocRepetitiveRepetitive Patronization PatternPatronization Pattern

Rel

ativ

e P

rofit

abili

tyR

elat

ive

Pro

fitab

ility

Hig

hH

igh

Med

ium

Med

ium

Low

Low“Volume Business”- Chronic Disease -

“Value Business” -Elective Surgery -

• Ophthalmology

• Medical Skincare

• Dialysis

• RT

• Long Term Care

• Logistics

• Preventive Medicine

• Medical Equipment Trading & Maintenance• Rehabilitation

• Pediatrics

• Obstetrics and Gynecology• ENT

• Hair Transplant• Anti-aging

““ ExcelsiorExcelsior ’’s Smiling Curves Smiling Curve ””Selected Competitive Arenas for Excelsior GroupSelected Competitive Arenas for Excelsior Group

7

Hemodialysis

Home Appliance

Medical Aesthetic

Medical Consumables

Trading Business

Product Planning

Information Analysis

Market Management

Creative Development

Sales Facilitation

Medical Information System

Professional Maintenance

Pharmaceutical Marketing & Logistic

Warehouse Management

Supporting

Hemodialysis Center

Ophthalmic/ Dental Clinic

Medical Aesthetic Clinic

Long-term Care/ Rehabilitation

Service Provider

8

Trading Business - Brand Agency

Home Appliances

Hemodialysis

Preventive Ventilator

9

Surgery

Product Structure

10

In thousands NTD

1,823,518,447 61.05%

656,428,374 21.98%

110,583,304 3.70%

206,499,292 6.91%

75,101,392 2.51%

28,680,504 0.96%

85,941,386 2.88%

HemodialysisSurgery

2010 Revenue Structure

Blood Bag

Home Appliances

VentilatorOstomy Others

11

Milestones

1980 1993 1997 2000 2001

˙Tony Medical founded to commencethe hemodialysis industry.

˙Establish hospital management.

˙Established long-termcare service.

˙Bestchain Healthtaiwan founded providing healthcare e-commercesolution.

˙Investing in E-Young Corp. for equipment maintenance.

2003

˙Sales contract with Tyco & Surgical.˙Investing in Visionfront Corp.

for Ophthalmology.

˙Investing in Excelsior Healthcare.˙EG Healthcare founded in Philippines.

12

Milestones (Con.)

2004 2007 2008 2009 2010 2011

˙Investing in Dynamic MedicalTechnologies, entering medicalaesthetic industry.

˙Investing in Bestsmile Corp.for dentistry.

˙Establishing Asia Best Healthcare alliedwith Lung Yen Life Service for the long-termcare market in China.

˙Pao-Ai Holding Corp. foundedestablishing Pao-Ai ophthalmologyclinic in China.

˙Strategic alliance with Arich Pharma Group in pharmaceutical logistics.

˙Incorporating cosmetheuticals intoDynamic Medical Technologies.

˙Investing in Perfection Healthcare.

˙ Investing in Hidens Dental.˙Distribute GlamSmile.

˙Start Excelsior HK Co., Ltd.˙JV with SinoPharm (1099.hk).

13

Related Cooperate and Oversea Business Units

˙ ARICH Enterprise Co., Ltd. ˙ Animation Medical Technologies Ltd.

˙ Bestsmile Co., Ltd. ˙ Visionfront Corporation Co., Ltd.

˙ RTS Excelsior Inc. ˙ Sunrise Health Care Company.

˙ E-Young Tech Co., Ltd. ˙ Dynamic Medical Technologies Inc.

˙ Bestchain Healthtaiwan Co., Ltd.

˙SinoExcelsior Healthcare Incorporation.

˙ Excelsior Medical (HK) Co., Ltd.

˙ Hong Kong Pacific Bo Ai Investment Ltd.

˙ Excelsior Healthcare (ShangHai) Corporation.

˙ Great China Technology Development Ltd.

˙ EG Healthcare, Inc.

˙ Excelsior Renal Service Co., Ltd.

˙ Asia Best Healthcare Co., Ltd.

14

15

Market ShareMarket Share ：：：：：：：：

KeelangKeelangKeelangKeelang

TaipeiTaipeiTaipeiTaipeiTaoyuan

Taoyuan

Taoyuan

TaoyuanHsinchu

Hsinchu

Hsinchu

HsinchuMiaoliMiaoliMiaoliMiaoli

YilanYilanYilanYilan

TaichungTaichungTaichungTaichung

ChanghaChanghaChanghaChangha

YunlinYunlinYunlinYunlin

NantouNantouNantouNantou HualinHualinHualinHualin

ChiayiChiayiChiayiChiayi

TainanTainanTainanTainan

Kaohsiung

Kaohsiung

Kaohsiung

Kaohsiung

Pingtung

Pingtung

Pingtung

Pingtung

TaitungTaitungTaitungTaitung

10: 10: 10: 10: 1111

JinmenJinmenJinmenJinmen

PenghuPenghuPenghuPenghu

TaiwanTaiwanTaiwanTaiwan99Q499Q499Q499Q4

JiateJiateJiateJiate99Q499Q499Q499Q4

Market(%)Market(%)Market(%)Market(%)

NorthNorthNorthNorth 197197197197 29292929 14.7%14.7%14.7%14.7%CentralCentralCentralCentral 166166166166 56565656 33.7%33.7%33.7%33.7%SouthSouthSouthSouth 155155155155 20202020 12.9%12.9%12.9%12.9%EastEastEastEast 25252525 1111 4%4%4%4%TotalTotalTotalTotal 543543543543 106106106106 19.5%19.5%19.5%19.5%

65 : 65 : 65 : 65 : 8888

64 : 64 : 64 : 64 : 7 7 7 7

8 : 28 : 28 : 28 : 2

10 : 010 : 010 : 010 : 0

17: 17: 17: 17: 8888

5 : 05 : 05 : 05 : 0

21 : 21 : 21 : 21 : 2222

48 : 48 : 48 : 48 : 5555

27 : 1 27 : 1 27 : 1 27 : 1

28 : 28 : 28 : 28 : 2222

31 : 31 : 31 : 31 : 8888

17 : 17 : 17 : 17 : 5555

18 : 18 : 18 : 18 : 3333

29 : 29 : 29 : 29 : 9999

32 : 32 : 32 : 32 : 10101010

38 : 38 : 38 : 38 : 19191919

15 : 15 : 15 : 15 : 3333

19 : 319 : 319 : 319 : 3

41 : 41 : 41 : 41 : 8888

2 : 02 : 02 : 02 : 0

1 : 01 : 01 : 01 : 0

Data due: Jan. 2011

Related Cooperate – RTS (Dialysis)

16

Brand AgencyBrand Agency ：：：：：：：：

Business LocationsBusiness Locations ：：：：：：：：TaiwanTaiwan、、、、、、、、HongKongHongKong 、、、、、、、、 GuangZhou GuangZhou 、、、、、、、、ShangHaiShangHai。。。。。。。。

Related Cooperate – DMT (Aesthetic)

1. RF

2. Laser

3. Body Contouring

4. Dermal Filler

5. Cosmeceuticals

6. Skin Imagining System

7. Others

17

Flagship Center in XiZhiFlagship Center in XiZhi

Related Cooperate – Asia Best Healthcare (Long-Term Care)

18

Logistic CenterLogistic Center ：：：：：：：：

C Building(ARICH: 3&4 Floors)

Executive Building(Administration Office)

A Building(Warehouse without A/C)

B Building(Receiving / Departure)

Extension Area(ARICH Second Warehouse)

Global Bonded Area(Main Entrance)

Brand AgencyBrand Agency ：：：：：：：：

Related Cooperate – ARICH (Logistic)

Medical Service Provider – Business Units

HemodialysisHemodialysis

DentistryDentistry

RehabilitationRehabilitation

OphthalmologyOphthalmology

LongLong --Term CareTerm Care

HospitalsHospitals

Medical AestheticMedical Aesthetic

19

Medical Service Provider – Hemodialysis Centers

20

Medical Service Provider – Medical Aesthetic Clinics

21

Medical Service Provider – Dentistry Clinics

22

Medical Service Provider – Ophthalmology Clinics

23

Medical Service Provider – Long-Term Care

24

本業及重要轉投資近五年淨利圖本業及重要轉投資近五年淨利圖本業及重要轉投資近五年淨利圖本業及重要轉投資近五年淨利圖

In thousands NTD

25

本業及重要轉投資本業及重要轉投資本業及重要轉投資本業及重要轉投資2010年收入毛利年收入毛利年收入毛利年收入毛利

In million NTD

26

HemodialysisHemodialysis

LogisticLogisticAestheticAesthetic

DentistryDentistry LongLong --Term CareTerm Care

PhilippinePhilippineOversea businessOversea business

OphthalmologyOphthalmology

Excelsior(4104.tw) & SinoPharm(1099.hk) JVExcelsior(4104.tw) & SinoPharm(1099.hk) JV

27

SinoExcelsior(ShangHai)

SinoPharm(ShangHai)

51%

49%

Excelsior(Taiwan)

HemodialysisMedical AestheticOphthalmologyDentistryRehabilitation

Excelsior(HongKong)

Registered capital：500 million RMB

Long-Term Care

1. Taiwan successful experience roll-out.2. Expend channels as service provider.3. Acquire related product agency.4. Resource integration to IPO.

1. Operating and management know-how in medical

industry.2. Wide distribution channels experiences covering

hospitals and clinics.3. Equipment and consumables agency.

Excelsior and Sinopharm had conduct a strategy alliance to establish a service providing platform in China’s medical industry, with the combination of operating know-how and

nation-wide distributing channels.

Income Statements (Standalone)Income Statements (Standalone)

28

% % % %Revenues 2,345,544 100.00 2,212,293 100.00 2,986,752 100.00 2,862,880 100.00Costs 1,911,132 81.48 1,779,684 80.45 2,376,754 79.58 2,293,813 80.12Unrealized Gain on Inter-Affiliate Accounts 69,361 2.96 56,997 2.58 77,274 2.59 64,382 2.25

Realized Gain on Inter-Affiliate Accounts 70,991 3.03 56,945 2.57 77,207 2.58 65,257 2.28

Gross Margin 436,042 18.59 432,557 19.54 609,931 20.42 569,942 19.91Operating Expenses 292,044 12.45 275,239 12.44 395,285 13.23 438,061 15.30Net Margin 143,998 6.14 157,318 7.11 214,646 7.19 131,881 4.61Other Income 188,444 8.03 181,683 8.21 238,107 7.97 224,641 7.85Other Expenses 23,598 1.01 25,308 1.14 48,711 1.63 7,341 0.26Income Before TAX 308,844 13.17 313,693 14.18 404,042 13.53 349,181 12.20TAX 39,427 1.68 43,043 1.95 48,350 1.62 69,560 2.43Extraordinary Profits － － － － － － 32,329 1.13Net Income 269,417 11.49 270,650 12.23 355,692 11.91 311,950 10.90EPS 2.62 2.86 3.72 3.60

In thousands NTD2011Q3 2010Q3 2010 2009

Income Statements (Consolidated)Income Statements (Consolidated)

29

% % % %Revenues 13,404,453 100.00 11,304,264 100.00 15,355,606 100.00 14,300,782 100.00Costs 12,211,792 91.10 10,196,966 90.20 13,828,407 90.05 13,031,716 91.13Unrealized Gain on Inter-Affiliate Accounts 60,550 0.45 56,997 0.50 69,416 0.45 64,382 0.45

Realized Gain on Inter-Affiliate Accounts 61,525 0.46 56,945 0.50 69,763 0.45 65,257 0.46

Gross Margin 1,193,636 8.91 1,107,246 9.80 1,527,546 9.95 1,269,941 8.88Operating Expenses 802,313 5.99 721,329 6.38 1,052,197 6.85 927,491 6.49Net Margin 391,323 2.92 385,917 3.41 475,349 3.10 342,450 2.39Other Income 109,096 0.81 106,030 0.94 147,756 0.96 163,667 1.14Other Expenses 63,476 0.47 63,438 0.56 86,647 0.56 47,628 0.33Income Before TAX 436,943 3.26 428,509 3.79 536,458 3.49 458,489 3.21TAX 77,937 0.58 88,050 0.78 101,724 0.66 131,856 0.92Extraordinary Profits － － 32,329 0.23Consolidated Net Income 359,006 2.68 340,459 3.01 434,734 2.83 358,962 2.51Shareholders of HoldingCompany 269,417 2.01 270,650 2.39 355,692 2.32 311,950 2.18

Minor Equity 89,589 0.67 69,809 0.62 79,042 0.51 47,012 0.33EPS 2.62 0.00 2.86 0.00 3.72 3.60

In thousands NTD2011Q3 2010Q3 2010 2009

Balance SheetBalance Sheet

30

％ ％ ％ ％

Assets Current Assets 1,973,315 29.75 2,057,564 39.75 3,001,163 46.88 2,368,516 47.74 Cash and Cash Equivalents 346,511 5.22 668,730 12.92 1,599,440 24.98 992,573 20.01 Receivables 798,813 12.03 776,990 15.01 778,360 12.16 739,307 14.90 Inventories 675,115 10.18 550,487 10.63 553,097 8.64 581,698 11.73 Other Current Assets 46,300 0.70 33,340 0.64 70,266 1.10 54,938 1.11 Funds and Investments 3,922,360 59.12 2,362,596 45.64 2,637,998 41.20 1,978,325 39.88 Fixed Assets 676,716 10.20 704,407 13.61 703,708 10.99 584,453 11.78 Intangible Assets 20,619 0.31 21,992 0.42 21,273 0.33 4,324 0.09 Other Assets 41,219 0.62 29,851 0.58 38,078 0.59 25,378 0.51Total Assets 6,634,229 100.00 5,176,410 100.00 6,402,220 100.00 4,960,996 100.00Liabilities Current Liabilities 1,010,509 15.23 709,830 13.71 716,358 11.19 609,774 12.29 Short-Term Loan 180,000 2.71 104,000 2.01 146,000 2.28 － － Payables 677,859 10.22 449,664 8.69 427,606 6.68 478,404 9.64 Other Current Liabilities 6,147 0.09 30,823 0.60 142,752 2.23 131,370 2.65 Long-Term Liabilities 390,588 5.89 0 0.00 384,118 6.00 98,509 1.99 Other Liabilities 43,972 0.66 38,975 0.75 42,424 0.66 34,823 0.70Total Liabilities 1,445,069 21.78 748,805 14.47 1,142,900 17.85 743,106 14.98Stockholders Equity Capital 1,029,840 15.52 952,340 18.40 1,029,840 16.09 891,085 17.96 Common Stock to be issuedfrom CB － － － － － － 38,828 0.78 Capital surplus 2,224,236 33.53 1,480,379 28.60 2,186,219 34.15 1,392,425 28.07 Retained Earnings 2,000,899 30.16 1,903,900 36.78 1,988,942 31.07 1,821,618 36.72 Other Stockholders Equity (65,815) (0.99) 90,986 1.76 54,319 0.85 73,934 1.49Total Equity 5,189,160 78.22 4,427,605 85.53 5,259,320 82.15 4,217,890 85.02Total Liabilities & Equity 6,634,229 100.00 5,176,410 100.00 6,402,220 100.00 4,960,996 100.00

In thousands NTD2011.09.30 2010.09.30 2010.12.31 2009.12.31